AMPLIFICATION OF CLINICAL EFFICACY
OUR INNOVATIVE TECHNOLOGY
There is a clear medical need in Rheumatoid Arthritis today with available drugs failing to successfully treat many of the patients to disease remission
At Amplio Pharma AB, our comprehensive technological solutions help individuals achieve greater health.
For AMP101, we use our proprietary modified retention technology, to amplify the clinical effect of low dose Methotrexate, the no 1 treatment in Rheumatoid Arthritis.
For more information, contact us today.
"Great pharmaceuticals arise through listening to ALL stakeholders"
M. Mensonides
AMPLIFICATION OF CLINICAL EFFICACY
Changing the Game
With our innovative and insightful technology, we strive to enhance patients’ every day quality of life.
Founded in 2020. Get in touch to learn more.
Charlott Brunmark, PhD
CSO
Karin von Wachenfeldt, PhD
CEO
Marguerite Mensonides, PhD
COO
GET IN TOUCH
Amplio Pharma AB
Medicon Village
Scheelevägen 2, 223 63 Lund, Sweden
--